Literature DB >> 21333362

The developmental and acute phases of insulin-induced laminitis involve minimal metalloproteinase activity.

M A de Laat1, M T Kyaw-Tanner, A R Nourian, C M McGowan, M N Sillence, C C Pollitt.   

Abstract

Metalloproteinases have been implicated in the pathogenesis of equine laminitis and other inflammatory conditions, through their role in the degradation and remodelling of the extracellular matrix environment. Matrix metalloproteinases (MMPs) and their inhibitors are present in normal equine lamellae, with increased secretion and activation of some metalloproteinases reported in horses with laminitis associated with systemic inflammation. It is unknown whether these enzymes are involved in insulin-induced laminitis, which occurs without overt systemic inflammation. In this study, gene expression of MMP-2, MMP-9, MT1-MMP, ADAMTS-4 and TIMP-3 was determined in the lamellar tissue of normal control horses (n=4) and horses that developed laminitis after 48 h of induced hyperinsulinaemia (n=4), using quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). Protein concentrations of MMP-2 and MMP-9 were also examined using gelatin zymography in horses subject to prolonged hyperinsulinaemia for 6h (n=4), 12h (n=4), 24h (n=4) and 48 h (n=4), and in normal control horses (n=4). The only change in gene expression observed was an upregulation of MMP-9 (p<0.05) in horses that developed insulin-induced laminitis (48 h). Zymographical analysis showed an increase (p<0.05) in pro MMP-9 during the acute phase of laminitis (48 h), whereas pro MMP-2 was present in similar concentration in the tissue of all horses. Thus, MMP-2, MT1-MMP, TIMP-3 and ADAMTS-4 do not appear to play a significant role in the pathogenesis of insulin-induced laminitis. The increased expression of MMP-9 may be associated with the infiltration of inflammatory leukocytes, or may be a direct result of hyperinsulinaemia. The exact role of MMP-9 in basement membrane degradation in laminitis is uncertain as it appears to be present largely in the inactive form.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21333362     DOI: 10.1016/j.vetimm.2011.01.013

Source DB:  PubMed          Journal:  Vet Immunol Immunopathol        ISSN: 0165-2427            Impact factor:   2.046


  7 in total

1.  The role of inflammation and matrix metalloproteinases in equine endometriosis.

Authors:  Luca Aresu; Silvia Benali; Diana Giannuzzi; Roberto Mantovani; Massimo Castagnaro; Maria Elena Falomo
Journal:  J Vet Sci       Date:  2012-06       Impact factor: 1.672

2.  ECEIM consensus statement on equine metabolic syndrome.

Authors:  Andy E Durham; Nicholas Frank; Cathy M McGowan; Nicola J Menzies-Gow; Ellen Roelfsema; Ingrid Vervuert; Karsten Feige; Kerstin Fey
Journal:  J Vet Intern Med       Date:  2019-02-06       Impact factor: 3.333

3.  An investigation of the equine epidermal growth factor system during hyperinsulinemic laminitis.

Authors:  Melody A de Laat; Robert J Spence; Martin N Sillence; Christopher C Pollitt
Journal:  PLoS One       Date:  2019-12-05       Impact factor: 3.240

4.  Differential Proteomic Expression of Equine Cardiac and Lamellar Tissue During Insulin-Induced Laminitis.

Authors:  Allison Campolo; Matthew W Frantz; Melody A de Laat; Steven D Hartson; Martin O Furr; Véronique A Lacombe
Journal:  Front Vet Sci       Date:  2020-06-12

5.  MMP-9 Concentration in Peritoneal Fluid Is a Valuable Biomarker Associated with Endotoxemia in Equine Colic.

Authors:  Ann Kristin Barton; Ina-Gabriele Richter; Tanja Ahrens; Roswitha Merle; Abdollah Alalwani; Svenja Lilge; Katrin Purschke; Dirk Barnewitz; Heidrun Gehlen
Journal:  Mediators Inflamm       Date:  2021-01-05       Impact factor: 4.711

6.  Interleukin-17A pathway target genes are upregulated in Equus caballus supporting limb laminitis.

Authors:  Lynne Cassimeris; Julie B Engiles; Hannah Galantino-Homer
Journal:  PLoS One       Date:  2020-12-10       Impact factor: 3.240

Review 7.  Expression and regulation of facilitative glucose transporters in equine insulin-sensitive tissue: from physiology to pathology.

Authors:  Véronique A Lacombe
Journal:  ISRN Vet Sci       Date:  2014-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.